Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Histological Criteria that Distinguish Human and Mouse Bone Formed Within a Mouse Skeletal Repair Defect.

Xin X, Jiang X, Wang L, Mikael P, McCarthy MB, Chen L, Mazzocca AD, Nukavarapu S, Lichtler AC, Rowe DW.

J Histochem Cytochem. 2019 Jun;67(6):401-417. doi: 10.1369/0022155419836436. Epub 2019 Mar 8.

PMID:
30848692
2.

Direct cell-cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo.

Furuya M, Kikuta J, Fujimori S, Seno S, Maeda H, Shirazaki M, Uenaka M, Mizuno H, Iwamoto Y, Morimoto A, Hashimoto K, Ito T, Isogai Y, Kashii M, Kaito T, Ohba S, Chung UI, Lichtler AC, Kikuchi K, Matsuda H, Yoshikawa H, Ishii M.

Nat Commun. 2018 Jan 19;9(1):300. doi: 10.1038/s41467-017-02541-w.

3.

Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions.

Zujur D, Kanke K, Lichtler AC, Hojo H, Chung UI, Ohba S.

Sci Adv. 2017 May 12;3(5):e1602875. doi: 10.1126/sciadv.1602875. eCollection 2017 May.

4.

A potential translational approach for bone tissue engineering through endochondral ossification.

Mikael PE, Xin X, Urso M, Jiang X, Wang L, Barnes B, Lichtler AC, Rowe DW, Nukavarapu SP.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:3925-8. doi: 10.1109/EMBC.2014.6944482.

PMID:
25570850
5.

A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells.

Xin X, Jiang X, Wang L, Stover ML, Zhan S, Huang J, Goldberg AJ, Liu Y, Kuhn L, Reichenberger EJ, Rowe DW, Lichtler AC.

Stem Cells Transl Med. 2014 Oct;3(10):1125-37. doi: 10.5966/sctm.2013-0128. Epub 2014 Aug 13.

6.

DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.

Isaac J, Erthal J, Gordon J, Duverger O, Sun HW, Lichtler AC, Stein GS, Lian JB, Morasso MI.

Cell Death Differ. 2014 Sep;21(9):1365-76. doi: 10.1038/cdd.2014.82. Epub 2014 Jun 20.

7.

Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions.

Kanke K, Masaki H, Saito T, Komiyama Y, Hojo H, Nakauchi H, Lichtler AC, Takato T, Chung UI, Ohba S.

Stem Cell Reports. 2014 May 22;2(6):751-60. doi: 10.1016/j.stemcr.2014.04.016. eCollection 2014 Jun 3.

8.

Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.

Alaee F, Sugiyama O, Virk MS, Tang H, Drissi H, Lichtler AC, Lieberman JR.

Gene Ther. 2014 Feb;21(2):139-47. doi: 10.1038/gt.2013.66. Epub 2013 Nov 28.

9.

Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells.

Kuhn LT, Liu Y, Boyd NL, Dennis JE, Jiang X, Xin X, Charles LF, Wang L, Aguila HL, Rowe DW, Lichtler AC, Goldberg AJ.

Tissue Eng Part A. 2014 Jan;20(1-2):365-77. doi: 10.1089/ten.TEA.2013.0321. Epub 2013 Oct 4.

10.

Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells.

Repic D, Torreggiani E, Franceschetti T, Matthews BG, Ivcevic S, Lichtler AC, Grcevic D, Kalajzic I.

Connect Tissue Res. 2013;54(4-5):296-304. doi: 10.3109/03008207.2013.814646. Epub 2013 Aug 26.

11.

Comparison of proliferation and differentiation of calvarial osteoblast cultures derived from Msx2 deficient and wild type mice.

Marijanović I, Kronenberg MS, Erceg Ivkosić I, Lichtler AC.

Coll Antropol. 2009 Sep;33(3):919-24.

PMID:
19860126
12.

Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP.

Yin D, Wang Z, Gao Q, Sundaresan R, Parrish C, Yang Q, Krebsbach PH, Lichtler AC, Rowe DW, Hock J, Liu P.

Mol Ther. 2009 Nov;17(11):1967-78. doi: 10.1038/mt.2009.151. Epub 2009 Jul 14.

13.

A BAC-bacterial recombination method to generate physically linked multiple gene reporter DNA constructs.

Maye P, Stover ML, Liu Y, Rowe DW, Gong S, Lichtler AC.

BMC Biotechnol. 2009 Mar 13;9:20. doi: 10.1186/1472-6750-9-20.

14.

Development of high-throughput screening system for osteogenic drugs using a cell-based sensor.

Hojo H, Igawa K, Ohba S, Yano F, Nakajima K, Komiyama Y, Ikeda T, Lichtler AC, Woo JT, Yonezawa T, Takato T, Chung UI.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):375-9. doi: 10.1016/j.bbrc.2008.08.167. Epub 2008 Sep 20.

PMID:
18789892
15.

Roles of FGFR3 during morphogenesis of Meckel's cartilage and mandibular bones.

Havens BA, Velonis D, Kronenberg MS, Lichtler AC, Oliver B, Mina M.

Dev Biol. 2008 Apr 15;316(2):336-49. doi: 10.1016/j.ydbio.2008.01.035. Epub 2008 Feb 13.

16.

Expression and function of Dlx genes in the osteoblast lineage.

Li H, Marijanovic I, Kronenberg MS, Erceg I, Stover ML, Velonis D, Mina M, Heinrich JG, Harris SE, Upholt WB, Kalajzic I, Lichtler AC.

Dev Biol. 2008 Apr 15;316(2):458-70. doi: 10.1016/j.ydbio.2008.01.001. Epub 2008 Jan 16.

17.

Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.

Zhu M, Chen M, Lichtler AC, O'Keefe RJ, Chen D.

Osteoarthritis Cartilage. 2008 Jan;16(1):129-30. Epub 2007 Sep 20.

18.

Studies on the role of Dlx5 in regulation of chondrocyte differentiation during endochondral ossification in the developing mouse limb.

Chin HJ, Fisher MC, Li Y, Ferrari D, Wang CK, Lichtler AC, Dealy CN, Kosher RA.

Dev Growth Differ. 2007 Aug;49(6):515-21. Epub 2007 Jun 7.

PMID:
17555518
19.

Identification of a potent combination of osteogenic genes for bone regeneration using embryonic stem (ES) cell-based sensor.

Ohba S, Ikeda T, Kugimiya F, Yano F, Lichtler AC, Nakamura K, Takato T, Kawaguchi H, Chung UI.

FASEB J. 2007 Jun;21(8):1777-87. Epub 2007 Feb 22.

PMID:
17317722
20.

Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.

Chen M, Lichtler AC, Sheu TJ, Xie C, Zhang X, O'Keefe RJ, Chen D.

Genesis. 2007 Jan;45(1):44-50.

21.

Analysis of internal deletions of a rat Col1a1 promoter fragment in transfected ROS17/2.8 cells.

Ivkosić A, Kronenberg MS, Lichtler AC, Kream BE.

Coll Antropol. 2006 Jun;30(2):401-4.

PMID:
16848158
22.

Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.

Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE.

Bone. 2006 Sep;39(3):494-504. Epub 2006 Apr 27.

PMID:
16644298
23.

T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Long M, Slaiby AM, Hagymasi AT, Mihalyo MA, Lichtler AC, Reiner SL, Adler AJ.

J Immunol. 2006 Jan 15;176(2):1036-45.

24.

Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.

Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, Lichtler AC, Clark SH, Gronowicz GA.

J Bone Miner Res. 2005 Aug;20(8):1414-29. Epub 2005 Mar 14.

25.

Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.

Liu F, Woitge HW, Braut A, Kronenberg MS, Lichtler AC, Mina M, Kream BE.

Int J Dev Biol. 2004 Sep;48(7):645-53.

26.

Azoxymethane-induced pre-adipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells.

Dong M, Guda K, Nambiar PR, Nakanishi M, Lichtler AC, Nishikawa M, Giardina C, Rosenberg DW.

Carcinogenesis. 2004 Nov;25(11):2239-46. Epub 2004 Aug 5.

PMID:
15297369
27.

Dual reporter transgene driven by 2.3Col1a1 promoter is active in differentiated osteoblasts.

Marijanović I, Jiang X, Kronenberg MS, Stover ML, Erceg I, Lichtler AC, Rowe DW.

Croat Med J. 2003 Aug;44(4):412-7.

28.

Dlx5 regulation of mouse osteoblast differentiation mediated by avian retrovirus vector.

Erceg I, Tadić T, Kronenberg MS, Marijanović I, Lichtler AC.

Croat Med J. 2003 Aug;44(4):407-11.

29.

Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin.

Kalajzic I, Kalajzic Z, Hurley MM, Lichtler AC, Rowe DW.

J Cell Biochem. 2003 Apr 15;88(6):1168-76.

PMID:
12647299
30.

Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation.

Tadic T, Dodig M, Erceg I, Marijanovic I, Mina M, Kalajzic Z, Velonis D, Kronenberg MS, Kosher RA, Ferrari D, Lichtler AC.

J Bone Miner Res. 2002 Jun;17(6):1008-14.

31.

MSX2 expression in the apical ectoderm ridge is regulated by an MSX2 and Dlx5 binding site.

Pan ZZ, Kronenberg MS, Huang DY, Sumoy L, Rogina B, Lichtler AC, Upholt WB.

Biochem Biophys Res Commun. 2002 Jan 25;290(3):955-61.

PMID:
11798166
32.

Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.

Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D.

J Bone Miner Res. 2002 Jan;17(1):15-25.

33.

Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice.

Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, Rowe DW.

J Bone Miner Res. 2001 Dec;16(12):2222-31.

35.

Dlx5 induces expression of COL1A1 promoter contained in a retrovirus vector.

Tadić T, Erceg I, Stover ML, Rowe DW, Lichtler AC.

Croat Med J. 2001 Aug;42(4):436-9. Review.

36.

Col1a1-driven transgenic markers of osteoblast lineage progression.

Dacic S, Kalajzic I, Visnjic D, Lichtler AC, Rowe DW.

J Bone Miner Res. 2001 Jul;16(7):1228-36.

37.

Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells.

Kalajzic I, Stover ML, Liu P, Kalajzic Z, Rowe DW, Lichtler AC.

Virology. 2001 May 25;284(1):37-45.

38.

Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.

Stover ML, Wang CK, McKinstry MB, Kalajzic I, Gronowicz G, Clark SH, Rowe DW, Lichtler AC.

Mol Ther. 2001 Apr;3(4):543-50.

39.

Reduction of target gene expression by a modified U1 snRNA.

Beckley SA, Liu P, Stover ML, Gunderson SI, Lichtler AC, Rowe DW.

Mol Cell Biol. 2001 Apr;21(8):2815-25.

40.

Parathyroid hormone inhibits collagen synthesis and the activity of rat col1a1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae.

Bogdanovic Z, Huang YF, Dodig M, Clark SH, Lichtler AC, Kream BE.

J Cell Biochem. 2000 Feb;77(1):149-58.

PMID:
10679825
41.

Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation.

Dodig M, Tadic T, Kronenberg MS, Dacic S, Liu YH, Maxson R, Rowe DW, Lichtler AC.

Dev Biol. 1999 May 15;209(2):298-307.

43.

Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo.

Harrison JR, Kleinert LM, Kelly PL, Krebsbach PH, Woody C, Clark S, Rowe DW, Lichtler AC, Kream BE.

J Bone Miner Res. 1998 Jul;13(7):1076-83.

44.

1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice.

Bedalov A, Salvatori R, Dodig M, Kapural B, Pavlin D, Kream BE, Clark SH, Woody CO, Rowe DW, Lichtler AC.

Biochim Biophys Acta. 1998 Jul 9;1398(3):285-93.

PMID:
9655920
47.

Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice.

Dodig M, Kronenberg MS, Bedalov A, Kream BE, Gronowicz G, Clark SH, Mack K, Liu YH, Maxon R, Pan ZZ, Upholt WB, Rowe DW, Lichtler AC.

J Biol Chem. 1996 Jul 5;271(27):16422-9.

48.

A collagen enhancer-promoter construct in transgenic mice is markedly stimulated by ethanol administration.

Walton CM, Wu GY, Petruff CA, Clark SH, Lichtler AC, Wu CH.

Hepatology. 1996 Feb;23(2):310-5.

PMID:
8591857
49.

Differential regulation of COL2A1 expression in developing and mature chondrocytes.

Seghatoleslami MR, Lichtler AC, Upholt WB, Kosher RA, Clark SH, Mack K, Rowe DW.

Matrix Biol. 1995 Dec;14(9):753-64.

PMID:
8785590

Supplemental Content

Loading ...
Support Center